Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts
about
sameAs
Immunotoxicogenomics: gene expression and immunotoxicology in the age of genomicsAutoantibodies in systemic sclerosis: unanswered questionsA model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients.ArraySolver: an algorithm for colour-coded graphical display and Wilcoxon signed-rank statistics for comparing microarray gene expression dataGenetics and proteomics in scleroderma.Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.Dermatological applications of DNA array technology.Application of functional genomics in allergy and clinical immunology.Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosisAntibodies in scleroderma: direct pathogenicity and phenotypic associations.Learning more from microarrays: insights from modules and networks.Systemic and cell type-specific gene expression patterns in scleroderma skin.Progressive systemic sclerosis with intraoral manifestations: A case report and review.Scleroderma gene expression and pathway signatures.A rare case of hidebound disease with dental implications.Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease."Omics" Technologies and the Immune System (a) , (b).Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.Overlapping gene expression profiles indicative of antigen processing and the interferon pathway characterize inflammatory fibrotic skin diseases.Systematic approach to understanding the pathogenesis of systemic sclerosis.Activation of key profibrotic mechanisms in transgenic fibroblasts expressing kinase-deficient type II Transforming growth factor-{beta} receptor (T{beta}RII{delta}k).Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts.Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.MicroRNA array analysis of microRNAs related to systemic scleroderma.Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles.
P2860
Q24855057-55032A1A-A134-4C00-9250-B436699861A9Q28085026-C034713A-E709-4336-8B08-9009F27D965DQ30478833-8F9A94C5-A37C-4B57-BFA8-253312C02156Q31162625-428DA456-EFE8-4208-A50A-52A185F4506FQ33212756-79A3C97F-6449-4219-956C-25CC0AC7B457Q34102567-15B40979-FDE8-454E-8113-8E2081BD22D7Q34952667-0AC1DBEE-A27B-439F-AC7C-8FE11C61033DQ35544065-039AAC18-0ECA-45E9-A21D-7408ADA533FEQ35555901-16A6DA27-8B59-4C91-B867-80E32FD861F6Q35689015-6359CDD5-1EDC-4C01-BAB9-52008113B8E8Q36228043-E5E90576-1CF6-46A3-B665-ED03E456F2D2Q36349808-2D7D5A33-F13F-48EB-B1BD-420D385166F5Q37068144-C4A9AC6F-E6AC-43C5-9762-635D8F72A1E2Q37220552-1AD068C8-A230-4BC8-B6E0-AE0E283E8DE5Q37222249-F5273B3D-F641-4003-9AEF-AC46970DF279Q37570289-05A8E392-6D98-410D-960E-2ED4FEA8496AQ37658722-A5D645CE-E791-4FA7-97F5-5AB44A38100FQ37905787-E8DC095A-74B2-4EC8-BCC2-3D7381545541Q38175063-02ADD3B0-8B05-433B-9B7C-3F49522F791BQ39029340-97EDBEB5-1EEB-47BB-83D0-7E1E1B20CCF0Q42474271-FE48DA1E-939C-4155-A0D2-376DB19A60B7Q42738488-4CB73E21-E707-46E5-8CCB-FE01F6839060Q45217538-EE226BEE-5059-49C5-9BF9-25F52C4E6127Q51553464-078CF75F-8558-408C-9770-A6709A6A8D81Q54638915-CAC26C9B-C386-4D5E-96E1-EED080926B70
P2860
Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@ast
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@en
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@nl
type
label
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@ast
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@en
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@nl
prefLabel
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@ast
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@en
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@nl
P2093
P3181
P1476
Systemic sclerosis (scleroderm ...... sed in scleroderma fibroblasts
@en
P2093
P304
P3181
P356
10.4049/JIMMUNOL.167.12.7126
P407
P577
2001-12-15T00:00:00Z